Testing baricitinib for persistent long COVID symptoms
Treatments studied
Part of Infections, Lungs & breathing clinical trials.
This trial tests whether the anti-inflammatory drug baricitinib can improve persistent long COVID symptoms like brain fog, fatigue, and shortness of breath. You may qualify if you had COVID-19 at least 6 months ago and still have bothersome symptoms that affect your daily life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a positive COVID-19 test at least 6 months ago.
- You have at least one ongoing long COVID symptom, like brain fog, fatigue, or shortness of breath, that started or got worse after your infection.
- Your symptoms have lasted for at least 6 months and affect your daily life.
- You have some cognitive trouble (like memory or concentration issues), confirmed by a short questionnaire.
- You are willing to take a pill (baricitinib or placebo) and attend study visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if combining maraviroc and atorvastatin can help people with long COVID. You must have specific, persistent symptoms like brain fog, severe fatigue, or shortness of breath that started or got worse after a confirmed COVID-19 infection and have lasted over 6 months.
This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
This trial tests if hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) helps with long COVID symptoms, especially brain fog and thinking problems. It may be an option if you have had lingering symptoms for at least 2 months and can travel to one of the study sites.
This trial tests a medicine called Anktiva to see if it can help people with Long COVID. It's for adults who had a confirmed COVID-19 infection and now have lasting symptoms like fatigue, brain fog, or trouble breathing.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.